Manager TitleAgeSince
Chief Executive Officer 59 07/05/2024
Director of Finance/CFO - 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2006
Director TitleAgeSince
Director/Board Member 74 01/05/2006
Director/Board Member 41 10/08/2021
Director/Board Member 58 29/08/2023
Date Insider Type Main position Quantity % Market Cap.
07/05/24Others

Director

37,404 0.0101%
07/05/24Others

Chairman

40,552 0.0110%
07/05/24
Foris Ventures LLC
Issuer saleCompany 99,314,394 26.8864%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+100.00% - - 745K
+0.00%+3.44%+4.17%+51.52% 78.41B
+0.23%+5.20%-12.46%+17.61% 38.96B
+2.05%+1.93%-24.17%-32.49% 32.43B
-0.85%+3.54%+10.96%+21.25% 25.94B
+5.98%-5.86%+111.48%+3.60% 19.95B
+0.22%-2.19%+15.02%+3.98% 20.01B
-0.07%-6.18%-34.36%-36.19% 18.33B
+4.09%-13.82%+107.90%-38.34% 15.3B
+0.73%+1.69%-8.06%-6.71% 13.72B
Average +1.24%-2.40%+18.94%-1.75% 29.23B
Weighted average by Cap. +0.94%-0.12%+10.56%+11.53%
Logo Amyris, Inc.
Amyris, Inc. is a synthetic biotechnology company. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Company’s sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The Company leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.
Employees
1,598
  1. Stock Market
  2. Stocks
  3. AMRS Stock